Asserts MiniMed 640G w/ predictive hypo suspend by April 2016; hybrid closed loop by April 2017

Medtronic Diabetes shared new timeline hopes on its upcoming diabetes device pipeline at the JP Morgan Healthcare Conference on January 12. Notably, management expects to launch the MiniMed 640G/Enlite 3 CGM (predictive low glucose management) in the US by April 2016, and a hybrid closed loop system (one step closer to a fully automated ‘artificial pancreas’) – the MiniMed 670G – by April 2017!

Read more

Posted in Glucose & Insulin